| (210) | Number of the EPO application | 16716776 |
| (220) | Filing date of the EPO application | 2016.04.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 05/2019, 2019.01.30 |
| (110) | EPO patent number | 3277691 |
| (21) | Number of the application | e 2018 0130 |
| (71) | Name(s) of applicant(s), code of the country | Gilead Sciences, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | CAI Zhenhong R., US;
JIN Haolun, US;
LAZERWITH Scott E., US;
PYUN Hyung-Jung, US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD Sciences Inc., US; |
| (54) | Title of the invention | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 491/14 (2006.01.01); C07D 491/22 (2006.01.01); C07D 498/14 (2006.01.01); C07D 498/22 (2006.01.01); C07D 513/22 (2006.01.01); A61K 31/4375 (2006.01.01); A61P 31/18 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.03.31 |
| (30) | Priority | 201562142338 P, 2015.04.02, US |
| (86) | International application | PCT/US2016/025740, 2016.04.01 |
| (87) | International publication | WO 2016/161382, 2016.10.06 |